Advisory
Business Consulting
Strategic guidance to help your business navigate challenges and seize opportunities for growth.
Learn MoreIndustry Expertise
Medical Technology
R&D tax credits, FDA compliance cost tracking, and financial infrastructure for medical device companies and health technology innovators.
Financial Expertise for Medical Technology Companies
Medical technology companies operate at the intersection of healthcare regulation and technology innovation. The financial demands of FDA approval processes, clinical trial cost tracking, IP capitalization, and medical device excise tax compliance require specialized accounting expertise that understands both the healthcare and technology landscapes.
SMAART Company provides tailored financial services for medtech startups, established medical device manufacturers, and health IT companies. From R&D tax credit maximization on device development to revenue recognition for SaaS-based health platforms, we deliver the financial precision that medtech companies need to innovate and scale.
Core Directives
R&D Credit Maximization
Regulatory Cost Tracking
Investor-Ready Financials
Operational Milestones
01
Company Assessment
Evaluate your R&D pipeline, regulatory costs, revenue model, and current financial infrastructure.
02
R&D & Tax Strategy
Build a comprehensive R&D credit strategy and optimize your tax position across federal and state jurisdictions.
03
Financial Infrastructure
Implement investor-grade accounting systems, revenue recognition policies, and IP tracking frameworks.
04
Growth Support
Ongoing financial modeling, fundraising preparation, and strategic advisory through development milestones.
Included Services & Outcomes
R&D Tax Credit Documentation
FDA Compliance Cost Capitalization
Clinical Trial Expense Tracking
Medical Device Revenue Recognition
IP Valuation & Amortization
Venture Capital Fundraising Readiness
Stock Option & Equity Compensation Accounting
Multi-State Tax Compliance
MedTech Finance Built for Regulated Innovation.
SMAART supports medtech companies with R&D capitalization, FDA submission costs, revenue recognition on long-cycle device sales, and investor-ready reporting.
FAQ
Questions &
Answers
Get answers to the most common questions about our medical technology services.
Device design, prototyping, clinical testing, software development for connected devices, and manufacturing process development typically qualify. SMAART documents all qualified activities to maximize your federal and state R&D credits.
FDA submission costs may be capitalized or expensed depending on the stage and nature of the expenditure. SMAART applies proper GAAP treatment to ensure accurate financial reporting and optimal tax positioning.
Yes. We prepare investor-ready financials, build detailed projections, and organize data rooms for medtech venture capital fundraising.
Absolutely. We handle ASC 606 revenue recognition for health technology platforms, subscription billing models, and the unique compliance requirements of healthcare SaaS companies.
Innovate with Financial Confidence.
Partner with SMAART to maximize R&D credits, track regulatory costs accurately, and build the financial infrastructure your medtech company needs to scale.
Schedule ConsultationRelated Services
Explore Our Other Services
01 / 02
01 / 02
Related Insights
From the SMAART Blog
AI
The Future of AI for Small Business: What to Prepare for Over the Next Three Years
AI capabilities are evolving faster than any small business can fully follow. Rather than trying to predict specific tools, the practical approach is preparing for the directional shifts that will shape small business operations through 2028 and beyond.
Read Article
AI
Building an AI-First Culture in Your Small Business
AI deployment succeeds or fails largely on culture. Small businesses where AI becomes a capability, rather than a tool collection, share specific leadership practices, operational norms, and hiring patterns that make AI adoption compound over time.
Read Article
AI
AI for Professional Services Firms: Accountants, Lawyers, Consultants, and Agencies
Professional services firms, accounting, legal, consulting, agencies, face both the largest AI productivity opportunity and the highest risks of misuse. A framework for where to deploy AI confidently and where to exercise professional judgment.
Read Article